Belgium· BE-AMP-SAM163931-00

Tritace 2.5 mg

A ramipril product containing ramipril, registered in Belgium by Sanofi Belgium. The same ATC class is registered in 18 of our 19 countries.

ATC C09AA05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedTritace 2.5 mgATCC09AA05REGISTER NO.BE-AMP-SAM163931-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Ramipril is registered in 18 of 19 countries.

Countries holding a registration under ATC C09AA05 (ramipril), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 11 of them publish a price we can compare per daily dose

Ramipril · ATC C09AA05

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ramipril costs, country by country.

Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.026 in United States to $0.40 in Switzerland — a ×15 gap.

  • 5 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Ramipril · price per daily dose (2.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.40
  • ES Spain$0.098
  • FR France$0.096
  • IT Italy$0.073
  • US United States$0.026 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ramipril
Manufacturer
Sanofi Belgium
Country
Belgium (BE)
ATC code
C09AA05
ATC class
Ramipril
Defined daily dose
2.5 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    0430660
    EUR 9.53
  • be_apb
    0747618

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

458 interactions on record for ramipril.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ramipril · interactions on record

458 records

  • 11 severe
  • 166 moderate
  • 17 minor
  • 184 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium gluconateA12BA05severe
  • Potassium chlorideB05XA01severe

80 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ramipril in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ramipril products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Lannapril, Ramipril 1a Pharma
  • Bulgaria · Cardifriend, Cardifriend 10 Mg
  • Cyprus · Acapril, Ramimed
  • Czechia · Amprilan, Piramil
  • Germany · Delix, Delix P
  • Denmark · Alarimed, Polpril
  • Estonia · Ampril, Cardace
  • Spain · Acovil, Ramipril Alter Genéricos
  • Finland · Cardace, Ramipril Hexal
  • France · Ramipril Almus, Ramipril Arrow Generiques
  • United Kingdom (Northern Ireland) · Ramipril, Ramipril Accord Healthcare
  • Greece · Piramil, Ramisyn
  • Croatia · Ampril, Blocar
  • Hungary · Amprilan, Hartil
  • Ireland · Ramic, Ramilo
  • Iceland · Ramíl
  • Italy · Herzatec, Krupil
  • Lithuania · Ampril, Cardace
  • Luxembourg · Ramipril Eg, Tritace
  • Latvia · Cardace, Ramicor
  • Malta · Ramipril Aurobindo, Ramipril Tad
  • Netherlands · Ramipril Accord, Ramipril Aurobindo
  • Norway · Ramipril Actavis, Ramipril Hexal
  • Poland · Ampril, Aporami
  • Portugal · Ramipril Alter, Ramipril Aurovitas
  • Romania · Ampril, Ramipril Ac
  • Sweden · Ramiliv, Ramipril Aurobindo
  • Slovenia · Ampril, Piramil
  • Slovakia · Ampril, Piramil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cb2a90d1-20e7-41cc-89bc-b962fc391903
GET /v1/drugs/cb2a90d1-20e7-41cc-89bc-b962fc391903?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Tritace 2.5 mg",
  "name_fr": "Tritace 2.5 mg",
  "name_nl": "Tritace 2.5 mg",
  "amp_code": "SAM163931-00",
  "strengths": [
    "2.5000",
    "2.5000",
    "0.5000"
  ],
  "pack_count": 19,
  "substances": [
    "Ramipril",
    "Sodium Stearyl Fumarate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ramipril",
  "authorisation_numbers": [
    "BE163931",
    "BE419544"
  ]
}

See everything about ramipril.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.